 "UAE approves Sinopharm's Covid vaccine for children aged three and over")
The United Arab Emirates has approved the emergency use of Sinopharm’s coronavirus vaccine for children, joining China in authorizing shots for those as young as three.
The decision to approve the vaccine for children aged three to 17 was based on the results of clinical studies and local evaluation, state-run WAM news agency said on Monday.
Few countries have so far approved vaccines for children as young as three. The UAE’s capital Abu Dhabi, Singapore, Hong Kong and some U.S. states have authorized shots for those aged 12 and above.
The Middle-Eastern nation has rolled out one of the fastest vaccination programs around the world, with 16.8 million shots administered in a population of 10 million.
The UAE has so far approved vaccines from Moderna Inc., Pfizer Inc. and AstraZeneca Plc. The inoculation program, though, has hinged on Sinopharm, which is being produced locally.
One subscription. Two world-class reads.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%